سعر راماسين 5مجم 7 اقراص 2022

Ramipril 5 mg oral tablets (7 per pack) marketed in Egypt; an angiotensin-converting enzyme (ACE) inhibitor.

• Treatment of hypertension, to lower blood pressurePopulation: AdultsDailyMed (U.S. National Library of Medicine)
• Reduction of the risk of myocardial infarction, stroke or cardiovascular death in patients 55 years or older at high cardiovascular riskPopulation: Adults 55 years or olderDailyMed (U.S. National Library of Medicine)
• Heart failure in stable patients after myocardial infarctionPopulation: AdultsDailyMed (U.S. National Library of Medicine)

• Most common adverse reactions in hypertension: headache, dizziness, fatigue and cough.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Hypersensitivity to ramipril or any other ACE inhibitor, including a history of angioedema with an ACE inhibitor or hereditary/idiopathic angioedema.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Combination with a neprilysin inhibitor (e.g. sacubitril); do not give within 36 hours of switching to or from sacubitril/valsartan.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Co-administration with aliskiren in patients with diabetes.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Angioedema, including intestinal angioedema, can occur at any time during ACE-inhibitor therapy.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Hypotension and hyperkalaemia may occur; renal function should be monitored during therapy. Rare cholestatic jaundice, hepatic failure, neutropenia and agranulocytosis are reported.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• DiureticsPossibility of excessive hypotension when starting ramipril in patients on diuretics.DailyMed (U.S. National Library of Medicine)
• LithiumUse with caution; lithium levels may rise.DailyMed (U.S. National Library of Medicine)
• NSAIDsMay increase risk of renal impairment and reduce the antihypertensive effect.DailyMed (U.S. National Library of Medicine)

• Drugs acting on the renin-angiotensin system used in the second and third trimesters reduce fetal renal function and increase fetal and neonatal morbidity and death; discontinue ramipril as soon as pregnancy is detected.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Because multiple doses may produce unpredictable low milk concentrations, the US label advises not to use ramipril in nursing mothers.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Ramipril: Prodrug converted to ramiprilat, which inhibits angiotensin-converting enzyme and reduces angiotensin II formation.